Condition

Recurrent Respiratory Papillomatosis

Treatments and trials tagged Recurrent Respiratory Papillomatosis, with the same country and access zoom as New Developments.

All New Developments

Recurrent Respiratory Papillomatosis breakthroughs

All countriesUnited StatesCanadaUnited KingdomJapanChinaAustraliaSwitzerlandEuropean UnionNewestPatient Stories
FDA ApprovedUnited States

First FDA-Approved Treatment for Adults With Recurrent Respiratory Papillomatosis

Papzimeos (zopapogene imadenovec-drba) — four subcutaneous shots over 12 weeks for adults with recurrent respiratory papillomatosis

FDA traditional/full approval on 14 August 2025 for Papzimeos (zopapogene imadenovec-drba) suspension — a non-replicating adenoviral vector…

This is for adults living with recurrent respiratory papillomatosis who still need repeated airway surgeries…